Literature DB >> 9838223

Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan.

T Sasaki1, H Yamada, K Matsumura, T Shimizu, A Kobata, T Endo.   

Abstract

alpha-Dystroglycan, which is a cell surface component of dystroglycan complex, is known to bind laminin in basal lamina of muscle cells and Schwann cells. We found previously that a novel O-glycan, Siaalpha2-3Galbeta1-4GlcNAcbeta1-2Man, is the major oligosaccharide in bovine peripheral nerve alpha-dystroglycan, and that this structure might mediate the binding of laminin. In order to determine whether this structure is specific for peripheral nerve alpha-dystroglycan or present on different forms of alpha-dystroglycan, we analyzed the structures of the sialylated O-glycans of rabbit skeletal muscle alpha-dystroglycan. Their structures were elucidated to be a mixture of a core 1 O-glycan and the same O-mannosyl glycan that we found in bovine peripheral nerve. These results indicate that alpha-dystroglycan in different species and tissues share a common structure of its major O-linked acidic carbohydrate, suggesting its relevance to the basic functional role of alpha-dystroglycan.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9838223     DOI: 10.1016/s0304-4165(98)00114-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  45 in total

1.  Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.

Authors:  Peng Zhang; Huaiyu Hu
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

2.  O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.

Authors:  Mauro Imperiali; Claudio Thoma; Ernesto Pavoni; Andrea Brancaccio; Nico Callewaert; Annette Oxenius
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 3.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

4.  Mutations in POMGNT1 cause non-syndromic retinitis pigmentosa.

Authors:  Mingchu Xu; Takeyuki Yamada; Zixi Sun; Aiden Eblimit; Irma Lopez; Feng Wang; Hiroshi Manya; Shan Xu; Li Zhao; Yumei Li; Adva Kimchi; Dror Sharon; Ruifang Sui; Tamao Endo; Robert K Koenekoop; Rui Chen
Journal:  Hum Mol Genet       Date:  2016-01-28       Impact factor: 6.150

Review 5.  Mammalian O-mannosylation: unsolved questions of structure/function.

Authors:  Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Curr Opin Struct Biol       Date:  2011-09-22       Impact factor: 6.809

Review 6.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

Review 7.  The dystroglycanopathies: the new disorders of O-linked glycosylation.

Authors:  Paul T Martin
Journal:  Semin Pediatr Neurol       Date:  2005-09       Impact factor: 1.636

8.  Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality.

Authors:  Tobias Willer; Belén Prados; Juan Manuel Falcón-Pérez; Ingrid Renner-Müller; Gerhard K H Przemeck; Mark Lommel; Antonio Coloma; M Carmen Valero; Martin Hrabé de Angelis; Widmar Tanner; Eckhard Wolf; Sabine Strahl; Jesús Cruces
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

9.  The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin.

Authors:  Jung Hae Yoon; Kumaran Chandrasekharan; Rui Xu; Matthew Glass; Neha Singhal; Paul T Martin
Journal:  Mol Cell Neurosci       Date:  2009-05-12       Impact factor: 4.314

10.  Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy.

Authors:  Huaiyu Hu; Joseph Candiello; Peng Zhang; Sherry L Ball; David A Cameron; Willi Halfter
Journal:  Mol Vis       Date:  2010-07-28       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.